Cargando…
IS ADENOSINE SAFE IN HOSPITALIZED PATIENTS WITH COVID-19 PNEUMONIA AND SUPRAVENTRICULAR TACHYCARDIA?
Autores principales: | Zivan, Tal, Ruiz, Ramon, Pavri, Behzad B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972590/ http://dx.doi.org/10.1016/S0735-1097(22)03095-9 |
Ejemplares similares
-
Safety of Adenosine for the Treatment of Supraventricular Tachycardia in Hospitalized Patients with COVID-19 Pneumonia
por: Zivan, Tal, et al.
Publicado: (2023) -
Ventricular tachycardia or supraventricular tachycardia?
por: Alasti, Mohammad, et al.
Publicado: (2022) -
Is the mechanism of these supraventricular tachycardias simply explained by reverse rotation?
por: Hayashida, Satoshi, et al.
Publicado: (2023) -
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME IN SIX PATIENTS FOLLOWING COVID-19 INFECTION
por: Parker, William, et al.
Publicado: (2021) -
OSBORNE WAVE IN ECG AS A PREDICTOR OF HOSPITAL MORTALITY IN COVID-19 ASSOCIATED PNEUMONIA
por: Zagidullin, Naufal, et al.
Publicado: (2021)